Significant Tic Reduction in An Otherwise Treatment-Resistant Patient with Gilles de la Tourette Syndrome Following Treatment with Nabiximols

Significant Tic Reduction in An Otherwise Treatment-Resistant Patient with Gilles de la Tourette Syndrome Following Treatment with Nabiximols

Early anecdotal reports and preliminary studies suggested that cannabinoid-based medicines such as delta-9-tetrahydrocannabinol (THC) are effective in the treatment of Gilles de la Tourette syndrome (TS). We report a single case study of a patient with otherwise treatment-resistant TS successfully t...

Full description

Bibliographic Details
Main Authors: Ahmad Seif Kanaan, Ewgeni Jakubovski, Kirsten Müller-Vahl
Format: Article
Language:English
Published: MDPI AG 2017-04-01
Series:Brain Sciences
Subjects:
Tourette syndrome
tic disorders
nabiximols
endocannabinoid system
Online Access:http://www.mdpi.com/2076-3425/7/5/47

Internet

http://www.mdpi.com/2076-3425/7/5/47

Similar Items